pembrolizumabnivolumabKEYNOTE-189KEYNOTE-407ipilimumabCM9LA
…ipilimumab/chemotherapy), against KEYNOTE-189, and KEYNOTE-407 (pembrolizumab/chemotherapy). We analyzed both the progression free survival (…
1articles mentioning drugs
3drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: KEYNOTE-407 ×
KEYNOTE-407
This drug is selected. Its supporting articles are shown below.